Table of contents
April 2006 Volume 2 No 4
Top of page
Viewpoint
Top of page
Research Highlights
Novel role for COX2 inhibitors in the treatment of N141I PSEN2 familial Alzheimer's disease?
176Could blockade of brain-derived neurotrophic factor be used to treat neuropathic pain?
176RPE cell implantation improves motor symptoms in patients with advanced PD
177Azathioprine therapy inhibits development of new lesions in multiple sclerosis patients
177Tau protein abnormalities correlate with the severity of dementia in Alzheimer's disease
178Computational models characterize cerebral aneurysms and assess risk of rupture
178NMDA receptors are present on oligodendrocyte processes and are activated during ischemia
179Deactivation of endocannabinoids in the brain helps treat depression
179Aspirin use before intracerebral hemorrhage increases mortality risk
180Myocardial infarction is associated with increased risk of subsequent stroke
180Efaproxiral is an effective addition to WBRT in patients with brain metastases
181Top of page
Practice Points
How effectively do rizatriptan and nontriptan drugs restore functional ability after acute migraine?
182Should patients surviving subarachnoid hemorrhage from a ruptured aneurysm be given follow-up screening?
184How strong is the evidence for the efficacies of different drug treatments for neuropathic pain?
186Top of page
Reviews
Therapy Insight: clinical management of pregnant women with epilepsy
190doi:10.1038/ncpneuro0153 | Full Text | PDF (192K)
Immunopathogenesis and immunotherapy of multiple sclerosis
201doi:10.1038/ncpneuro0154 | Full Text | PDF (332K)
Mechanisms of Disease: neurogenetics of MeCP2 deficiency
212doi:10.1038/ncpneuro0148 | Full Text | PDF (230K)
Mechanisms of Disease: congenital muscular dystrophies—glycosylation takes center stage
222doi:10.1038/ncpneuro0155 | Full Text | PDF (214K)
